Update on worldwide efforts to prevent type 1 diabetes

Annals of the New York Academy of Sciences

Volumn 1150, Issue , 2008, Pages 190-196

  Skyler, Jay S ^a,b  

^a DIABETES RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical trials; Immunomodulation; Prevention; Type 1 diabetes

Indexed keywords

INSULIN; NICOTINAMIDE;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG ELIMINATION; HUMAN; IMMUNOMODULATION; IMMUNOPATHOLOGY; INFANT FEEDING; INSULIN DEPENDENT DIABETES MELLITUS; INTERNATIONAL COOPERATION; MILK; ONSET AGE; RANDOMIZED CONTROLLED TRIAL;

EID: 57749178603     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1447.055     Document Type: Conference Paper

References (9)

1. Williams, A.J.K., P.J. Bingley, W.P.M. Moore & E.A.M. Gale, the ENDIT Screening Group. 2002. Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes. Diabetologia 45 : 217 223.
2. European Nicotinamide Diabetes Intervention Trial (ENDIT) Group, Gale EAM. 2003. Intervening before the onset of type 1 diabetes: baseline data from the European Nicotinamide Diabetes Intervention Trial (ENDIT). Diabetologia 46 : 339 346.
3. European Nicotinamide Diabetes Intervention Trial (ENDIT) Group. 2004. European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomized controlled trial of intervention before the onset of type 1 diabetes. Lancet 363 : 925 931.
4. Diabetes Prevention Trial-Type 1 Study Group. 2002. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N. Engl. J. Med. 346 : 1685 1691.
5. Diabetes Prevention Trial-Type 1 Diabetes Study Group. 2005. Effects of oral insulin in relatives of patients with type 1 diabetes mellitus. Diabetes Care 28 : 1068 1076.
6. Type 1 Diabetes TrialNet Oral Insulin Study. http://www2. diabetestrialnet.org/oins
7. Näntö-Salonen, K., A. Kupila, S. Simell, et al. 2008. Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial. Lancet 372 : 1746 1755.
8. TRIGR Study Group. 2007. Study design of the trial to reduce IDDM in the genetically at risk (TRIGR). Pediatr. Diabetes 8 : 117 137.
9. Keymeulen, B., E. Vandemeulebroucke, A.G. Ziegler, et al. 2005. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N. Engl. J. Med. 352 : 2598 2608.